BASF and Transinsight Collaborate in Exploring Alternatives to Animal Testing

Go3RBASF SE and Transinsight GmbH, a provider of semantic search technologies for Web 2.0, have agreed to establish close cooperation in the area of semantic analyses to search for alternatives to animal testing. Together with the German Federal Institute for Risk Assessment, both companies will expand the first specialized semantic search engine for this research area called www.Go3R.org to become a global internet platform. In the future, experts from all over the world will be able to use this platform to bring together their knowledge on alternative and supplementary methods to animal testing.

For over 20 years, BASF has been committed to establishing alternative and supplementary methods. Since 2004, the company has been developing and validating alternatives to animal testing in its own alternatives laboratory with a research budget of 2 million euros per year. Even now alternative methods are employed in 25 percent of all the company's tests. "We are striving to increase this proportion. Transinsight's semantic search supports us in this endeavour. With the help of this highly promising technology, we - just like any other potential user - can browse the internet, internal sources, patents and specialized databases much more efficiently than before when searching for information on meaningful approaches to new alternative methods", explains Dr Robert Landsiedel, Head of the Short Term Toxicology Department at BASF.

Transinsight's semantic search engine also finds related terms and web pages that are relevant for the respective search term and thus provides considerably more accurate and comprehensive search results than conventional full text search engines. "Go3R will make a tremendous contribution to improving the process of searching for information on alternative methods", states Dr Michael R. Alvers, CEO of Transinsight. "To achieve this, we are transferring the Wikipedia concept – the largest internet encyclopaedia compiled by the community – to semantic networks of terms. Currently, this is the most efficient way to achieve a large knowledge base within a short period of time and thus to significantly reduce the amount of animal testing in the long term", Alvers continues. The www.Go3R.org platform is already available online. The service is free of charge.

Related news articles:

About Transinsight
Transinsight develops knowledge-based semantic solutions in the Life Sciences. Their flagship products www.Go3R.org and www.GoPubMed.com, renowned biomedical search engines, are the first knowledge-based search systems of the next generation for the Life Sciences on the internet. In acknowledgement of the technologies developed by the company, Transinsight has repeatedly been honoured with international awards. The firm works in close collaboration with the Dresden University of Technology. Selected customers are: Unilever, BASF, BfR, StatoilHydro, Wintershall, AbCam and EMBL. For further information on Transinsight on the internet, see www.transinsight.com.

About BASF
BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from oil and gas to chemicals, plastics, performance products, agricultural products and fine chemicals. As a reliable partner, BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges, such as climate protection, energy efficiency, nutrition and mobility. BASF has more than 95,000 employees and posted sales of almost 58 billion euros in 2007. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at www.basf.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...